Showing results (1021-1030 of 1,376) with videos related to
Sort By:
Pageof 138
Neuro-Oncology Advances|August 20, 2026
Beyond the typical immune effector cell-associated neurotoxicity syndrome: Characterizing non-immune effector cell-associated neurotoxicity syndrome neurological complications in chimeric antigen receptor T-cell therapy-A retrospective analysisMelissa A Nicholas, Abdulaziz Abu-Haimed, Faisal Abushullaih, et al.Neuro-Oncology Advances|September 8, 2026
Metabolomic and lipidomic profiling reveals distinct subtypes of glioblastoma IDH-wildtype and shared metabolic features with astrocytoma IDH-mutant grade 4John Paul Aboubechara, Yin Liu, Oliver Fiehn, et al.Neuro-Oncology Advances|September 9, 2026
Perineuronal net degradation in aggressive glioblastomas with KANK1::NTRK2 fusionsMadhumala K Sadanandappa, Nishika Karbhari, Brizha Knowles, et al.Neuro-Oncology Advances|September 10, 2026
[18F]FET PET imaging for early response assessment of bevacizumab in recurrent glioblastomaShivani Chiranth, Otto Mølby Henriksen, Benedikte Hasselbalch, et al.Neuro-Oncology Advances|August 14, 2026
The cell surface proteome of malignant peripheral nerve sheath tumors reveals therapeutic targetsChristopher M Stehn, Liangjun Wang, Davis Seelig, et al.Neuro-Oncology Advances|August 15, 2026
Arterial spin-labeling-based exchange time mapping for differentiation of high-grade glioma and brain metastasesPhilipp Raffler, Gabriel Hoffmann, Matthias Günther, et al.Neuro-Oncology Advances|September 24, 2026
Re-resection at first recurrence is associated with prolonged survival in young patients with high-grade glioma: A multi-center studyDavid A Giles, Jing Wang, Markus Anzaldua-Campos, et al.Neuro-Oncology Advances|September 18, 2026
Single-cell RNA sequencing reveals compartment-specific immune and tumor cell states in a contiguous spinal metastasisYassmin A Elbanna, Kenny K H Yu, Tejus A Bale, et al.Neuro-Oncology Advances|October 1, 2026
Permeabilization of tumor margins in brain macrometastases using a type-1 receptor selective tumor necrosis factor muteinVanessa A Johanssen, Claire Bristow, Sandra J Campbell, et al.Pageof 138